Latest Blogs

Jul 01, 2020
 In this strange and socially distant year, I wanted to offer a few words of encouragement to our medical graduates in Lebanon and around the world.
Jun 29, 2020
Assumptions are the opposite of open communication; they remain unsaid and often expand to include thoughts that are unrelated to the initial feeling.
Jun 22, 2020
Pervasive bias has been in this country for centuries, and quiet microaggressions and larger macroaggressions have been given a pass for far too long.
Jun 18, 2020
ASCO Ethics Committee chair Dr. Jonathan Marron and I discuss two recommendations from a recent paper on allocating scarce health care resources during COVID-19.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Apr 01, 2020
The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.
Sep 09, 2019
A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.
Jul 02, 2019
Regardless of prognosis, we all must live with the reality that time is fleeting, and none of us have unlimited tomorrows.
Aug 31, 2018
Some reflections on John McCain, mortality, Hamilton, and the story you leave behind. 
Dec 21, 2016
I cannot count the number of times I have thought to myself, “If it were not for the PSA, you would no doubt be out there playing golf, skiing, biking, taking a grandchild to the park, or just enjoying life.” Living from one PSA to the next is a bad way to mark the passing of time.
Aug 08, 2016
For prostate cancer, there are both challenges and some early positive results from immunotherapy trials that remain intriguing. One of the key challenges is identifying those patients who will benefit from the treatment.

Pages